Skip to main content
. 2021 Feb 11;11:3677. doi: 10.1038/s41598-021-83118-y

Table 1.

The selected baseline characteristics of the study participants by the status of MetS.

Characteristics FMD MMD MetS
N (%) 16,886 (35.55) 22,480 (47.33) 8129 (17.12)
Age (years), mean ± SD 40.6 ± 11.8 47.8 ± 13.5 52.6 ± 13.0
Age group, n (%)
20–29 2752 (16.30) 1764 (7.85) 259 (3.19)
30–39 5780 (34.23) 4863 (21.63) 1145 (14.09)
40–49 5020 (29.73) 6440 (28.65) 2033 (25.01)
50–59 2001 (11.85) 4480 (19.93) 2030 (24.97)
60–69 948 (5.61) 3265 (14.52) 1725 (21.22)
70 +  385 (2.28) 1668 (7.42) 937 (11.53)
Sex, n (%)
Men 4296 (25.44) 9397 (41.80) 3679 (45.26)
Women 12,590 (74.56) 13,083 (58.20) 4450 (54.74)
Systolic blood Pressure (mmHg) 109.7 ± 10.9 127.5 ± 18.9 139.1 ± 19
Diastolic Blood Pressure (mmHg) 70.1 ± 7.4 80 ± 11.8 86.2 ± 13.2
Fasting glucose (mg/dl) 84.5 ± 6.8 92.5 ± 23.8 115.7 ± 48.4
Total cholesterol (mg/dl) 184.9 ± 33.5 195 ± 38.9 207.7 ± 42.1
Triglyceride (mg/dl) 74 ± 28.4 119.5 ± 88.8 230.2 ± 183.5
HDL cholesterol (mg/dl) 64.6 ± 12.4 56.6 ± 13.7 47.2 ± 12.3
Criteria
Abnormal central Obesity, n (%) 6061 (26.96) 6206 (76.34)
Hypertriglyceridemia, n (%) 4812 (21.41) 5960 (73.32)
Low level of HDL, n (%) 4810 (21.40) 4332 (53.29)
High blood pressure, n (%) 12,190 (54.23) 6839 (84.13)
Impaired glucose Tolerance, n (%) 3650 (16.24) 4649 (57.19)

FMD free of MetS, MMD mild metabolic disorder with 1–2 criteria.